Novartis Data definition

Novartis Data means all data, information, documents or records of whatever nature (including personal data and Novartis confidential information) and in whatever form and whether subsisting before or after the date of the Agreement and whether created or processed by Third Party in connection with the services provided to Novartis or provided by Novartis (or third parties acting on their behalf) to Third Party in connection with the Agreement.
Sample 1Sample 2Sample 3
Novartis Data means, with respect to a given Licensed Product, the preclinical and clinical data generated by or on behalf of Novartis or its Affiliates in the course of its preclinical (if any) and clinical Development of such Licensed Product on or after the Effective Date of this Agreement, which Development is [*] and which [*].
Sample 1Sample 2Sample 3
Novartis Data means all information, data and writings provided to the Supplier by and/or on behalf of Novartis in connection with the Contract, in any form whatsoever, which were owned by or licensed to Novartis prior to being provided to the Supplier.
Sample 1Sample 2

Examples of Novartis Data in a sentence

  • Some of Xxxxxxx’x key projects include CoServ Electric Utility (2.6 MW), Toyota North American Headquarters (8.8 MW) Oncor Electric Delivery’s Microgrid facility, Alconƒ Novartis Data Center and United Foods Distribution Facility.

  • For studies using paper CRFs, data will be entered into a fully validated study database by Novartis Data Management personnel (or designated CRO).

  • Face-to-face meetings allowed us to communicate key points more directly and discuss issues in a more diverse way.

  • Following entry from the CRFs, the data are systematically checked by Novartis Data Management personnel (or designated CRO) using programmed checks and data review tools/reports.

  • Company submission Doc B bibliography number 45: Novartis (Data on File): Multiple Sclerosis Advisory Board.

  • The Novartis Data Protection and Information Security Requirements shall be finalized prior to the time at which CBMG first processes Personal Data (as such term is defined in Part A, Section 9 of Schedule 15.4(c)) pursuant to this Agreement or any Ancillary Agreement.

  • Supplier shall acquire no right, title or interest in the Novartis Data in the Deliverables.

  • Supplier shall acquire no right, title or interest in the Novartis Data.

  • Until the time of application of these provisions, the provision of Article 9 of the Law on the Prevention of Money Laundering (RS Official Gazette, No 107/05 as amended in 117/05) shall apply.

  • Supplier will engage and report to Novartis if there is any actual or suspected Security Incident which could impact Novartis or Novartis Data.


More Definitions of Novartis Data

Novartis Data means all data, documents or records of whatever nature (including Personal Data and Novartis Confidential Information) and in whatever form relating to the business of Novartis including details of customers, employees or otherwise, whether subsisting before or after the date of the Agreement and whether created or processed as part of, or in connection with, the Services or provided by Novartis (or third parties acting on their behalf) to Supplier in connection with the Agreement;
Sample 1
Novartis Data shall have the meaning set forth in Section 11.1. of Annex C.
Sample 1
Novartis Data means all data, documents or records of whatever nature (including Personal Data and Novartis Confidential Information) and in whatever form relating to the business of Novartis including details of customers, employees or otherwise, whether subsisting before or after the date of the Agreement and whether created or processed as part of, or in connection with, the Services or provided by Novartis (or third Parties acting on their behalf) to CBMG China in connection with the Agreement;
Sample 1

Related to Novartis Data

  • BMS means the Company, all related companies, affiliates, subsidiaries, parents, successors, assigns and all organizations acquired by the foregoing.

  • Novartis shall have the meaning set forth in the Preamble.

  • Merck has the meaning set forth in the preamble.

  • Study Data shall have the meaning set forth in Section 8.1.

  • Clinical Data means the information concerning the safety or performance that is generated from the use of a device and that are sourced from the following:

  • Pfizer shall have the meaning set forth in the preamble.

  • Research Data means documents in a digital form, other than scientific publications, which are collected or produced in the course of scientific research activities and are used as evidence in the research process, or are commonly accepted in the research community as necessary to validate research findings and results;

  • Licensee Data means, other than Resultant Data, information, data and other content, in any form or medium, that is collected, downloaded or otherwise received, directly or indirectly from Licensee or an Authorized User by or through the Services.

  • Product Data are illustrations, standard schedules, performance charts, instructions, brochures, diagrams, and other information furnished by the Contractor to illustrate materials or equipment for some portion of the Work.

  • SAP Technology Solution(s means SAP NetWeaver Foundation for Third Party Applications, SAP Business Technology Platform (excluding when used solely as a Connectivity App between an SAP Application and ERP), SAP Signavio Solutions and SAP Process Insights (including any renamed, prior and/or successor versions of any of the foregoing made generally available by SAP if any but excluding when any of the foregoing are used as a User Interface for ERP.

  • Development Data means all non-clinical, clinical, technical, chemical, safety, and scientific data and information and other results, including relevant laboratory notebook information, screening data, and synthesis schemes, including descriptions in any form, data and other information, in each case, that is generated by or resulting from or in connection with the conduct of Development of Products.

  • GSK has the meaning set forth in the preamble.

  • ISIS means the department’s individualized services information system.

  • Third Party Materials means materials and information, in any form or medium, including any software, documents, data, content, specifications, products, equipment or components of or relating to the Services that are not proprietary to NCIT.

  • Third Party Material means software, software development tools, methodologies, ideas, methods, processes, concepts and techniques owned by, or licensed to a third party and used by the Service Provider in the performance of the Services;

  • Third Party Data has the meaning set forth in Section 9.3(a).

  • Regulatory Data means any and all research data, pharmacology data, chemistry, manufacturing, and control data, preclinical data, clinical data or all other documentation submitted, or required to be submitted, to Regulatory Authorities in association with regulatory filings for the Product in the Field (including any Drug Master Files (DMFs), Chemistry, Manufacturing and Control (“CMC”) data, or similar documentation).

  • Siemens means Siemens AG (Germany) and its Affiliates.

  • Third-party filer means an entity that submits a Product filing to the Commission on behalf of an Insurer.

  • Regulatory Materials means regulatory applications, submissions, notifications, registrations, Marketing Authorizations or other written materials, correspondence, submissions made to or with a Regulatory Authority that are necessary or reasonably desirable in order to Develop, Manufacture or Commercialize the Licensed Products in the Field in a particular country.

  • Elan means Elan Corp and its Affiliates.

  • Third Party Technology means all Intellectual Property and products owned by third parties and licensed pursuant to Third Party Licenses.

  • Licensed Technology means the Licensed Patents and the Licensed Know-How.

  • Bioassay means the determination of kinds, quantities or concentrations and, in some cases, the locations of radioactive material in the human body, whether by direct measurement, in vivo counting, or by analysis and evaluation of materials excreted or removed from the human body. For purposes of these rules, “radiobioassay” is an equivalent term.

  • Collaboration Technology means all Collaboration Patents and Collaboration Know-How.

  • Study Materials means all the materials and information created for the Study, or required to be submitted to the Sponsor including all data, results, Biological Samples, Case Report Forms (or their equivalent) in whatever form held, conclusions, discoveries, inventions, know-how and the like, whether patentable or not, relating to the Study, which are discovered or developed as a result of the Study, but excluding the Institution’s ordinary patient records.